Trade Summary

6 days ago, BURNETT JOSEPH, serving as CEO and President at ClearPoint Neuro, Inc. (CLPT), sold 61,843 shares at $17.79 per share, for a total transaction value of $1,100,463.42. Following this transaction, BURNETT JOSEPH now holds 191,388 shares of CLPT.

This sale represents a 24.42% decrease in BURNETT JOSEPH's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 4:05 PM ET, 5 days after the trade was made.

ClearPoint Neuro, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.